This cohort study assesses differences in secondary treatment receipt and mortality among Black and White patients with localized prostate cancer.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Racial Variations in Secondary Treatment and Survival in Prostate Cancer | 0 | 7.35 | 21-07-2026 |
| 2 | Long-Term Adverse Effects and Complications After Prostate Cancer Treatment | 0 | 9.73 | 01-12-2024 |
| 3 | Prostate Cancer Mortality After Relabeling Low-Grade Prostate Cancer as Precancerous | 0 | 9.66 | 01-07-2026 |
| 4 | Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer | 0 | 5 | 18-06-2026 |
| 5 | Rates of Systemic Treatment for Metastatic Non–Small Cell Lung Cancer Among Older Adults | 0 | 5.92 | 01-07-2026 |
| 6 | Organ Preservation and QOL After Total Neoadjuvant Treatment in Rectal Cancer | 0 | 7.94 | 15-10-2026 |
| 7 | Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases | 0 | 7 | 03-07-2026 |
| 8 | Magnetic Resonance Imaging in Prostate Cancer Screening | 0 | 9.31 | 01-06-2024 |
| 9 | Troponin Screening and Major Cardiovascular Adverse Events During ICI Therapy | 0 | 7.02 | 21-07-2026 |
| 10 | Quality of Life and Socioeconomic Disadvantage in Patients With Head and Neck Cancer | 0 | 5.26 | 01-08-2026 |